Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Development of novel hamster-L5 model to investigate pathophysiology of atherosclerosis

April 25, 2019

Positive results presented from phase II/III TAZPOWER study of elamipretide

April 17, 2019

Positive interim results presented from phase I study of CERC-301

April 16, 2019

Sorrento Therapeutics expands clinical development program for resiniferatoxin

April 15, 2019

Fully human stem cells show heart muscle regeneration promise

April 9, 2019

United Therapeutics discontinues development of esuberaprost based on BEAT results in PAH

April 8, 2019

Stem cell-derived human 'hearts' identify new cardiac drugs

April 4, 2019

Repair enables regeneration for blood vessels

April 4, 2019

Proteo initiates clinical development of subcutaneous Elafin

April 1, 2019

Angion Biomedica identifies Rho-associated protein kinase 1/2 inhibitors

March 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...